| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACO1
|
aconitase 1, soluble
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANKK1
|
ankyrin repeat and kinase domain containing 1
|
|
AP3B1
|
adaptor-related protein complex 3, beta 1 subunit
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
ARHGEF10L
|
Rho guanine nucleotide exchange factor (GEF) 10-like
|
|
AS3MT
|
arsenite methyltransferase
|
|
ASIP
|
agouti signaling protein
|
|
ATRN
|
attractin
|
|
AURKA
|
aurora kinase A
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BAX
|
BCL2-associated X protein
|
|
BCCIP
|
BRCA2 and CDKN1A interacting protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCND1
|
cyclin D1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD28
|
CD28 molecule
|
|
CD3EAP
|
CD3e molecule, epsilon associated protein
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CLPTM1
|
cleft lip and palate associated transmembrane protein 1
|
|
CLPTM1L
|
CLPTM1-like
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DRD2
|
dopamine receptor D2
|
|
DUSP14
|
dual specificity phosphatase 14
|
|
EDN1
|
endothelin 1
|
|
EDNRB
|
endothelin receptor type B
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ESR1
|
estrogen receptor 1
|
|
EXOC2
|
exocyst complex component 2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBRSL1
|
fibrosin-like 1
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOXE1
|
forkhead box E1
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GLI1
|
GLI family zinc finger 1
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNG2
|
guanine nucleotide binding protein (G protein), gamma 2
|
|
GPX1
|
glutathione peroxidase 1
|
|
GSTA4
|
glutathione S-transferase alpha 4
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HAL
|
histidine ammonia-lyase
|
|
HDAC9
|
histone deacetylase 9
|
|
HERC2
|
HECT and RLD domain containing E3 ubiquitin protein ligase 2
|
|
HFE
|
hemochromatosis
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HPS1
|
Hermansky-Pudlak syndrome 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH2
|
histamine receptor H2
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA10
|
interferon, alpha 10
|
|
IFNA14
|
interferon, alpha 14
|
|
IFNA16
|
interferon, alpha 16
|
|
IFNA17
|
interferon, alpha 17
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNA21
|
interferon, alpha 21
|
|
IFNA5
|
interferon, alpha 5
|
|
IFNA6
|
interferon, alpha 6
|
|
IFNA8
|
interferon, alpha 8
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNE
|
interferon, epsilon
|
|
IFNG
|
interferon, gamma
|
|
IFNK
|
interferon, kappa
|
|
IFNW1
|
interferon, omega 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IHH
|
indian hedgehog
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITGA10
|
integrin, alpha 10
|
|
ITGA11
|
integrin, alpha 11
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGA7
|
integrin, alpha 7
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB4
|
integrin, beta 4
|
|
ITGB5
|
integrin, beta 5
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLC1
|
kinesin light chain 1
|
|
KLF14
|
Kruppel-like factor 14
|
|
KLHL9
|
kelch-like family member 9
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT5
|
keratin 5, type II
|
|
LIG3
|
ligase III, DNA, ATP-dependent
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LTA
|
lymphotoxin alpha
|
|
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MBS1
|
Moebius syndrome 1
|
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MGRN1
|
mahogunin ring finger 1, E3 ubiquitin protein ligase
|
|
MIR146A
|
microRNA 146a
|
|
MIR34A
|
microRNA 34a
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MLANA
|
melan-A
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUTYH
|
mutY homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCL
|
v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH7B
|
myosin, heavy chain 7B, cardiac muscle, beta
|
|
MYO5A
|
myosin VA (heavy chain 12, myoxin)
|
|
MYO7A
|
myosin VIIA
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NID1
|
nidogen 1
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
OA1
|
Osteoarthritis QTL 1
|
|
OCA2
|
oculocutaneous albinism II
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PADI6
|
peptidyl arginine deiminase, type VI
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX3
|
paired box 3
|
|
PDGFD
|
platelet derived growth factor D
|
|
PHB
|
prohibitin
|
|
PIGU
|
phosphatidylinositol glycan anchor biosynthesis, class U
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAA
|
phospholipase A2-activating protein
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POMC
|
proopiomelanocortin
|
|
POT1
|
protection of telomeres 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1R13B
|
protein phosphatase 1, regulatory subunit 13B
|
|
PTCH1
|
patched 1
|
|
PTCH2
|
patched 2
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RCC2
|
regulator of chromosome condensation 2
|
|
RECQL4
|
RecQ protein-like 4
|
|
RET
|
ret proto-oncogene
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RGS22
|
regulator of G-protein signaling 22
|
|
RHOU
|
ras homolog family member U
|
|
RMI1
|
RecQ mediated genome instability 1
|
|
RNASEL
|
ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent)
|
|
RNH1
|
ribonuclease/angiogenin inhibitor 1
|
|
RTEL1
|
regulator of telomere elongation helicase 1
|
|
SHFM1
|
split hand/foot malformation (ectrodactyly) type 1
|
|
SHH
|
sonic hedgehog
|
|
SLC24A4
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 4
|
|
SLC24A5
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 5
|
|
SLC45A2
|
solute carrier family 45, member 2
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SMO
|
smoothened, frizzled class receptor
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX10
|
SRY (sex determining region Y)-box 10
|
|
STX17
|
syntaxin 17
|
|
SUFU
|
suppressor of fused homolog (Drosophila)
|
|
TDG
|
thymine-DNA glycosylase
|
|
TERF1
|
telomeric repeat binding factor (NIMA-interacting) 1
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGM3
|
transglutaminase 3
|
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNKS2
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TUSC1
|
tumor suppressor candidate 1
|
|
TYR
|
tyrosinase
|
|
TYRP1
|
tyrosinase-related protein 1
|
|
UBAC2
|
UBA domain containing 2
|
|
VASH2
|
vasohibin 2
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VPS13B
|
vacuolar protein sorting 13 homolog B (yeast)
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
ZFYVE21
|
zinc finger, FYVE domain containing 21
|
